Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | BMY | GILD | VRTX |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 275.55 | 333.93 | 49.41 | 83.37 | 483.78 |
| High | 277.58 | 339.00 | 50.18 | 84.52 | 483.78 |
| Low | 271.38 | 331.00 | 48.78 | 82.76 | 473.75 |
| Last | 273.15 | 332.92 | 49.74 | 83.89 | 474.16 |
| Change | -1.31 | +0.12 | +0.25 | +0.84 | -7.10 |
| % Change | -0.48% | +0.04% | +0.51% | +1.01% | -1.48% |
| Volume | 655,900 | 1,366,700 | 7,771,400 | 9,199,399 | 868,200 |
| 20-Day Average Volume | 909,495 | 1,736,285 | 8,557,130 | 6,438,015 | 980,545 |
| Previous Close | 274.46 | 332.80 | 49.49 | 83.05 | 481.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 266.52 | 329.25 | 49.06 | 79.63 | 480.27 |
| 20-Day Raw Stochastic | 66.25% | 69.60% | 73.87% | 90.09% | 34.05% |
| 20-Day Relative Strength | 58.42% | 55.28% | 57.58% | 71.85% | 47.32% |
| Weighted Alpha | +41.52 | +25.51 | -9.39 | +18.22 | +32.08 |
| Today's Opinion | 96% Buy | 88% Buy | 72% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 96% Buy | 88% Buy | 72% Buy | 88% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 72% Buy | 24% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.29% since 09/11/24 | +0.89% since 09/11/24 | +2.37% since 09/11/24 | +3.64% since 09/11/24 | -0.12% since 09/11/24 |
| Low | 259.01 on 09/13/24 | 326.41 on 09/12/24 | 47.76 on 09/12/24 | 81.57 on 09/13/24 | 468.46 on 09/12/24 |
| High | 277.58 on 09/18/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.89 on 09/12/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +1.83% since 08/16/24 | +3.57% since 08/16/24 | +0.77% since 08/16/24 | +13.70% since 08/16/24 | -0.67% since 08/16/24 |
| Low | 244.88 on 09/06/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 73.27 on 08/19/24 | 460.69 on 09/11/24 |
| High | 287.55 on 08/29/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +77.53% since 06/18/24 | +8.80% since 06/18/24 | +21.88% since 06/18/24 | +32.84% since 06/18/24 | +1.47% since 06/18/24 |
| Low | 153.23 on 06/20/24 | 303.55 on 06/20/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 |
| High | 287.55 on 08/29/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | +85.30% since 03/18/24 | +22.89% since 03/18/24 | -3.59% since 03/18/24 | +14.51% since 03/18/24 | +15.26% since 03/18/24 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 287.55 on 08/29/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,716,992 | 178,525,568 | 100,321,184 | 103,468,096 | 124,190,592 |
| Shares Outstanding, K | 126,492 | 536,435 | 2,027,100 | 1,245,853 | 258,053 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 659,830,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -16,890,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 0.38 | 0.61 | 0.46 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.56 on 08/01/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 10/29/24 | 10/31/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.02 | 36.49 | 17.69 | 0.00 |